UniSa - IRIS Institutional Research Information System

PICILLO, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.719
NA - Nord America 6.835
EU - Europa 2.456
SA - Sud America 981
AF - Africa 72
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 4
Totale 26.137
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 12.124
US - Stati Uniti d'America 6.680
SG - Singapore 1.787
BR - Brasile 826
CN - Cina 783
IT - Italia 562
RU - Federazione Russa 470
VN - Vietnam 426
UA - Ucraina 335
DE - Germania 245
IE - Irlanda 226
KR - Corea 176
TR - Turchia 161
SE - Svezia 158
GB - Regno Unito 112
CA - Canada 81
FI - Finlandia 74
EE - Estonia 69
IN - India 68
AR - Argentina 58
AU - Australia 43
MX - Messico 43
BD - Bangladesh 40
NL - Olanda 39
PL - Polonia 37
JP - Giappone 33
ES - Italia 26
EC - Ecuador 25
NZ - Nuova Zelanda 25
AT - Austria 23
IQ - Iraq 23
CO - Colombia 20
ZA - Sudafrica 20
CZ - Repubblica Ceca 19
FR - Francia 19
VE - Venezuela 18
ID - Indonesia 15
PK - Pakistan 15
MA - Marocco 12
PY - Paraguay 11
UZ - Uzbekistan 11
KE - Kenya 10
IL - Israele 9
CL - Cile 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
NP - Nepal 7
BO - Bolivia 6
JM - Giamaica 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
PA - Panama 5
BE - Belgio 4
ET - Etiopia 4
EU - Europa 4
GT - Guatemala 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
GE - Georgia 3
LU - Lussemburgo 3
MD - Moldavia 3
OM - Oman 3
PE - Perù 3
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CY - Cipro 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
RW - Ruanda 2
SN - Senegal 2
SO - Somalia 2
TN - Tunisia 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CU - Cuba 1
CV - Capo Verde 1
DK - Danimarca 1
DM - Dominica 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
Totale 26.118
Salva come PNG Salva come JPEG
Città #
Hong Kong 12.116
Ann Arbor 1.168
Singapore 813
Princeton 612
Chandler 520
Wilmington 468
Dallas 466
Jacksonville 409
Ashburn 385
Houston 300
San Jose 287
Dublin 219
Woodbridge 180
Beijing 164
Dong Ket 144
Izmir 143
Moscow 124
Andover 117
Nanjing 109
Ho Chi Minh City 97
Naples 97
Boardman 82
Los Angeles 81
The Dalles 79
Pellezzano 76
Tallinn 69
Hanoi 68
Salerno 66
Norwalk 62
São Paulo 61
Munich 55
New York 55
Dearborn 46
Düsseldorf 46
Shenyang 44
Fairfield 37
Redwood City 37
West Jordan 35
Changsha 34
Mestre 34
Nanchang 32
Rio de Janeiro 32
Warsaw 30
Montreal 29
Santa Clara 29
Seoul 28
Tokyo 28
Columbus 27
Hebei 27
Nuremberg 26
Pune 25
Rome 25
Council Bluffs 24
Orem 23
Stockholm 23
Belo Horizonte 22
Jiaxing 22
Brasília 21
Curitiba 21
San Francisco 20
Amsterdam 18
Milan 18
Sydney 18
Seattle 17
Boston 16
Brooklyn 16
San Diego 15
Tianjin 15
Washington 15
Johannesburg 14
Lecce 14
Atlanta 13
Auckland 13
Haiphong 13
Manchester 13
Poplar 13
Porto Alegre 13
Turku 13
Chennai 12
Denver 12
Guangzhou 12
Guarulhos 12
Lappeenranta 12
Phoenix 12
Baghdad 11
Brno 11
Ribeirão Preto 11
Campinas 10
Da Nang 10
Guayaquil 10
Nairobi 10
Frankfurt am Main 9
Mexico City 9
Tashkent 9
Ankara 8
Cambridge 8
Chicago 8
Ottawa 8
Shanghai 8
Toronto 8
Totale 21.006
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.173
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 969
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 935
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 921
Sex Differences in Parkinson’s Disease: From Bench to Bedside 633
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 562
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 526
Gender differences in microRNA expression in levodopa-naive PD patients 525
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 500
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 486
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 449
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 444
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 435
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 397
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 372
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 343
Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada 328
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 314
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 311
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 306
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 304
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 296
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 295
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 270
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 249
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 208
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 203
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 195
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 192
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 180
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 164
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 160
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 153
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 150
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 144
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 144
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 137
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 136
Increased bilirubin levels in de novo Parkinson's disease 135
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 129
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 129
Quitting smoking: An early non-motor feature of Parkinson's disease? 127
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 127
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 124
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 123
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 123
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 121
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 120
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 119
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 119
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 116
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 115
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 112
PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family 109
Gender and non motor fluctuations in Parkinson's disease: A prospective study 108
The relevance of gender in Parkinson's disease: a review 106
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 105
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 103
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 102
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 102
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 102
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 101
Early MRI findings in acquired hepatocerebral degeneration. 99
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 99
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Sep;132(Pt 9):2350-5. PMID: 19584099 98
Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards 98
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 98
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 97
Impact of COVID-19 on neurological patients attending a botulinum toxin service 97
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale 96
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 95
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 95
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 95
Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family 95
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 95
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 93
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 93
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 93
Non-motor correlates of smoking habits in de novo Parkinson's disease 92
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 91
Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms 91
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 90
Uric acid relates to dopamine transporter availability in Parkinson's disease. 90
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 89
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 89
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 89
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 88
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 88
The language profile of progressive supranuclear palsy 86
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 86
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 85
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 85
Resting brain networks in patients with Parkinson's disease and freezing of gait 84
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 84
Deep Brain Stimulation Target Selection for Parkinson's Disease 84
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 83
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 81
Evolution of mild cognitive impairment in Parkinson disease 81
Progressive Supranuclear Palsy-Like Phenotype in a GBA E326K Mutation Carrier 81
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 81
Totale 20.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021443 0 0 0 0 0 0 90 5 72 5 84 187
2021/2022956 11 3 6 12 11 4 18 34 132 117 138 470
2022/20231.387 183 95 70 109 180 309 16 125 189 9 72 30
2023/2024947 52 116 44 65 34 113 42 83 61 78 79 180
2024/20252.692 84 26 46 164 106 233 341 248 465 315 344 320
2025/202616.105 3.579 5.250 4.530 721 1.114 484 427 0 0 0 0 0
Totale 26.615